Coronary Angiogram: Comprehensive Clinical Overview
Indications
Coronary angiography should be performed when the patient is a candidate for revascularization and when benefits outweigh risks, with specific clinical scenarios dictating urgency.
Class I Indications (Must Perform)
Stable Ischemic Heart Disease:
- Survivors of sudden cardiac death or life-threatening ventricular arrhythmia 1
- Patients with heart failure symptoms requiring assessment for ischemic etiology 1
- Unacceptable angina despite optimal medical therapy that limits quality of life 1
- High-risk noninvasive stress test findings (large ischemic burden, ST-segment depression ≥2mm, hypotensive response, extensive perfusion defects) 2, 1
Acute Coronary Syndromes (NSTEMI/Unstable Angina):
- Recurrent ischemia at rest or with minimal activity despite medical therapy 3
- Heart failure symptoms with S3 gallop, pulmonary edema, or new mitral regurgitation 3
- Hemodynamic instability or hypotension with angina 3
- Sustained ventricular tachycardia 3
- Elevated troponin with high-risk features 4, 5
- Depressed LV function (EF <40%) 3
Timing for ACS: High-risk patients should undergo angiography within 48 hours, though those with severe ongoing ischemia, major arrhythmias, or hemodynamic instability require catheterization within 1 hour 4.
Class IIa Indications (Reasonable to Perform)
- Depressed LV function (EF <50%) with moderate-risk noninvasive testing showing ischemia 1
- Inconclusive noninvasive testing or contraindication to stress testing 1
- Preserved LV function (EF >50%) with intermediate-risk stress test and unsatisfactory quality of life from angina 1
Class III Indications (Should NOT Perform)
- Patients unwilling to undergo revascularization regardless of findings 1, 3
- Preserved LV function with low-risk stress test criteria 1
- Asymptomatic patients without ischemia on noninvasive testing 1
- Extensive comorbidities where revascularization risks exceed benefits 3
Pre-Procedure Preparation
Antiplatelet Management
For Stable Ischemic Heart Disease (Elective PCI):
- Do NOT routinely pretreat with P2Y12 inhibitors before elective angiography 6
- If PCI is performed, administer clopidogrel 600mg loading dose in the catheterization laboratory 6
- Continue chronic aspirin therapy if already prescribed 6
For NSTEACS:
- If angiography expected ≤24 hours: Do NOT pretreat with P2Y12 inhibitors 6
- If angiography expected >24 hours: Pretreat with P2Y12 inhibitor (ticagrelor 180mg, prasugrel 60mg, or clopidogrel 600mg) 6
- Exception: If high suspicion for CABG anatomy, avoid pretreatment even with delayed angiography 6
Patient Assessment and Informed Consent
Critical risk factors requiring explicit discussion:
- Advanced age >70 years 2, 7
- Severe LV dysfunction or known left main disease 2, 7
- Renal insufficiency or diabetes (increased contrast-induced nephropathy risk) 2, 7
- Bleeding disorders 2, 7
- History of contrast allergy 2, 7
- Severe comorbidities (hepatic, pulmonary disease) 2, 7
Informed consent must explicitly cover:
- Procedural risks (death, stroke, MI, bleeding, vascular damage, contrast nephropathy, arrhythmias) 2
- Benefits specific to patient's clinical scenario 2
- Alternative diagnostic strategies 2
Procedure Steps
Coronary angiography defines coronary anatomy including location, diameter, severity of stenosis, collateral flow, and identifies lesions ≥70% diameter reduction (≥50% for left main disease) as significant 1.
Vascular Access
- Ultrasound guidance increases first-attempt success and reduces venipuncture compared to anatomic landmarks alone 8
- Radial or femoral approach based on operator expertise and patient anatomy 9
Imaging Protocol
- Multiple angiographic views to visualize all three major coronary arteries (LAD, circumflex, right coronary) 1
- Assessment of dominance pattern (right, left, or codominant) 1
- Left ventriculography to assess wall motion and ejection fraction 9
- Aortography if indicated 9
Adjunctive Testing (When Indicated)
- Fractional Flow Reserve (FFR) for angiographically intermediate lesions (40-70% stenosis) to determine hemodynamic significance 7
- Intravascular ultrasound or optical coherence tomography for precise stenosis assessment and plaque characterization 7
Risks and Complications
Overall complication rate for diagnostic angiography is 1.5% based on ACC National Cardiovascular Data Registry 2012 data 2.
Major Complications
- Death, stroke, myocardial infarction 2, 10
- Vascular damage requiring intervention 2, 10
- Emergency revascularization 2
Common Complications
- Bleeding/hematoma: 4.5-8.8% depending on access site and technique 10, 11
- Contrast-induced nephropathy: Higher risk with renal insufficiency, diabetes 2, 7
- Contrast allergic/anaphylactoid reactions 2, 10
- Arrhythmias 2, 10
- Pseudoaneurysm: ~1% 11
- Arteriovenous fistula: rare 11
Risk Mitigation
- Careful patient selection balancing risks against likelihood of finding critical CAD 2
- Adequate hydration for contrast nephropathy prevention 2
- Ultrasound-guided access to reduce vascular complications 8
- Experienced operators in appropriate facilities 2
Post-Procedure Care
Immediate Management
Vascular Access Site:
- Modern guidelines support reduced bed rest duration (no longer requiring 6 hours flat) 11
- 30-degree head elevation is acceptable 11
- Sandbags are not necessary 11
- Monitor for bleeding, hematoma, pseudoaneurysm 11
Antiplatelet Therapy Post-Procedure
If PCI Performed:
- Continue aspirin indefinitely 5
- Clopidogrel: minimum 1 month, ideally up to 1 year 5
- For ACS: ticagrelor 90mg twice daily or prasugrel 10mg daily preferred over clopidogrel 5
If CABG Planned:
- Continue aspirin 5
- Stop clopidogrel 5-7 days before elective CABG 5
- Stop ticagrelor/prasugrel per institutional protocol 5
- More urgent surgery may proceed if bleeding risk acceptable 5
If No Revascularization:
Risk Stratification for Conservative Management
Low-risk patients (no recurrent chest pain, no ST changes, negative troponin):
- Perform stress test before discharge 5, 3
- If stress test shows significant ischemia, proceed to angiography 5
- If low-risk on stress test, discharge with medical therapy 5
Monitoring Duration
- Outpatient procedures have comparable safety to inpatient when properly selected 12
- Early ambulation and discharge feasible with modern hemostasis techniques 12
- Complication rates may be lower in carefully selected outpatient populations 12
Critical Pitfalls to Avoid
Do not perform angiography in patients unwilling to undergo revascularization - this violates fundamental appropriateness criteria 1, 3
Do not routinely pretreat with P2Y12 inhibitors for elective cases - evidence shows no benefit and potential harm from unnecessary bleeding if CABG needed 6
Do not skip informed consent discussion of contrast nephropathy risk in diabetics and those with renal insufficiency - this is a predictable and potentially preventable complication 2, 7
Do not rely solely on angiographic appearance for intermediate lesions (40-70% stenosis) - FFR assessment changes management in these cases 7
Do not assume technical quality is adequate - 48% of angiograms in one audit had technical deficiencies affecting interpretation 1